Medical Treatment & Drug Development
Pandemics & Infectious Diseases
Bacteria & Other Microorganisms
Zoonose & Vector Borne Diseases
Climate Adaptation & Resilience
Post-Doctoral Fellowships
France
Bacterial Armor Provides Protection, but Possible Treatments, Too
Back in the lab, Dr. Thibeaux will check for live Leptospira bacteria surviving inside the biofilms. This would mean that, contrary to current beliefs about the disease, Leptospira can reproduce in the environment, outside of a mammalian host. He’ll then investigate how, precisely, the biofilms work to protect the bacteria: What is their composition and how are they organized? Using advanced microscopy, he’ll even be able to observe their assembly over time.
These results will provide a thorough description of how Leptospira biofilms operate, offering new clues for evaluating the risk of leptospirosis outbreaks, as well as a much deeper understanding of the physical and chemical factors influencing the bacteria’s survival. Dr. Thibeaux’s work could indicate ways to impair their ability to generate biofilms, suggesting strategies for public health interventions that could make Leptospira vulnerable to the host’s immune system and to harsh conditions in the environment. Leptospirosis is already costly and can be life threatening; with the number of cases expected to increase to over a million per year worldwide, new approaches to treatment and prevention are badly needed.
Scientific title: Leptospires Bacterial Biofilm: An Unexplored Reservoir For Environmental Survival And Persistence Of Infectious Bacteria
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Roman
THIBEAUX
Institution
Institut Pasteur
New Caledonia
Country
France
Nationality
French
Related articles
Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Drug Delivery
Biotech- and Nanotechnology
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more
Laurence
SABATIER
Institut du médicament de Strasbourg
Medical Treatment & Drug Development
Antimicrobials, Antibiotics & Drug Resistances
Bacteria & Other Microorganisms
Drug Delivery
Mécénat des Mutuelle
France
New Molecule to Combat Antibiotic-Resistant Childhood Sepsis
The global spread of antibiotic resistance requires the identification of new bacterial drug targets, the design and synthesis of innovative... Read more
Nalini
RAMA RAO